- Dry eye disease (DED) is a complex eye condition, and this review summarizes current and future treatment options for it by looking at research from PubMed, FDA, and other databases.
- Current FDA-approved treatments for DED include several cyclosporine formulations, lifitegrast (XIIDRA), and various medical devices designed to improve tear production and treat meibomian gland dysfunction.
- Numerous clinical trials are ongoing to evaluate new treatments for DED, including various novel drops and solutions, aiming to enhance symptomatic relief as well as overall management of the disease.